BRIEF published on 08/15/2025 at 07:35, 7 months 4 days ago Sensorion Strengthens its Liquidity Contract with Kepler Cheuvreux Liquidity Biotechnology Euronext Kepler Cheuvreux Sensorion
BRIEF published on 08/15/2025 at 07:35, 7 months 4 days ago Sensorion Renforce son Contrat de Liquidité avec Kepler Cheuvreux Euronext Biotechnologie Kepler Cheuvreux Liquidité Sensorion
PRESS RELEASE published on 08/15/2025 at 07:30, 7 months 4 days ago Informations privilégiées / Autres communiqués Sensorion augmente les moyens du contrat de liquidité avec Kepler Cheuvreux conformément à la décision de l'AMF. Détails des actions et du montant ajouté Biotechnologie Kepler Cheuvreux Liquidité AMF Sensorion
PRESS RELEASE published on 08/15/2025 at 07:30, 7 months 4 days ago Inside Information / Other news releases Sensorion increases resources allocated to liquidity contract with Kepler Cheuvreux by €60,000 to enhance liquidity of shares on Euronext Paris. The move is in accordance with AMF Decision No. 2021-01 Euronext Paris Liquidity Contract Kepler Cheuvreux AMF Decision Sensorion
BRIEF published on 07/31/2025 at 09:22, 7 months 19 days ago Sensorion Announces Participation in Investor Conferences Biotechnology Investor Conferences Sensorion Hearing Therapies September-October 2025
BRIEF published on 07/31/2025 at 09:22, 7 months 19 days ago Sensorion annonce sa participation à des conférences d'investisseurs Biotechnologie Conférences Investisseurs Sensorion Thérapies Auditives Septembre-Octobre 2025
PRESS RELEASE published on 07/31/2025 at 09:17, 7 months 19 days ago Informations privilégiées / Autres communiqués Sensorion annonce sa participation à plusieurs conférences investisseurs à venir en septembre et octobre 2025. La société présentera ses avancées dans le domaine de la biotechnologie et des thérapies pour la perte auditive Biotechnologie Conférences Investisseurs Sensorion Perte Auditive Thérapies Auditives
BRIEF published on 07/01/2025 at 07:35, 8 months 18 days ago Sensorion publie des données préliminaires positives issues de l'essai de phase 1/2 d'Audiogene Thérapie Génique Sensorion SENS-501 Surdité Congénitale Essai Audiogene
BRIEF published on 07/01/2025 at 07:35, 8 months 18 days ago Sensorion Reports Positive Preliminary Data from Audiogene Phase 1/2 Trial Gene Therapy Sensorion SENS-501 Congenital Deafness Audiogene Trial
PRESS RELEASE published on 07/01/2025 at 07:30, 8 months 18 days ago Inside Information / Other news releases Sensorion announces positive data from the first cohort of the Audiogene Phase 1/2 Gene Therapy Clinical Trial, showing safety and hearing improvement in toddlers. Second cohort recruitment near completion Gene Therapy Clinical Trial Sensorion Audiogene Hearing Improvement
Published on 03/20/2026 at 00:20, 2 hours 40 minutes ago Prospect Ridge To Host Investor Webinar With Presentation And Audience Q&A
Published on 03/20/2026 at 00:20, 2 hours 40 minutes ago Reeflex Solutions Inc. Announces Revocation of Management Cease Trade Order
Published on 03/19/2026 at 21:16, 5 hours 44 minutes ago Unusual Machines, Inc. Announces Proposed Public Offering
Published on 03/19/2026 at 14:20, 12 hours 40 minutes ago CBMJ CEO Rips Legacy Liberal Media Over Iran Coverage on The Schaftlein Report
Published on 03/19/2026 at 13:50, 13 hours 10 minutes ago Predictiv AI Appoints Multi-Agent Systems Pioneer Professor George Rzevski as Strategic Advisor to Advance Swarm AI Platforms
Published on 03/19/2026 at 23:48, 3 hours 11 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Appendix 3C daily buy back notice
Published on 03/19/2026 at 22:55, 4 hours 4 minutes ago Baristas behind millions of cups of coffee compete globally
Published on 03/19/2026 at 22:48, 4 hours 11 minutes ago EQS-Adhoc: Forecast for the 2026 financial year
Published on 03/19/2026 at 19:24, 7 hours 35 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 03/19/2026 at 18:00, 9 hours ago Mise à disposition du Document d’Enregistrement Universel 2025
Published on 03/19/2026 at 08:45, 18 hours 15 minutes ago Deezer et Sonos renouvellent et étendent leur partenariat stratégique
